Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Pharm Bull (Tokyo) ; 64(10): 1474-1483, 2016 Oct 01.
Article in English | MEDLINE | ID: mdl-27452927

ABSTRACT

We have developed a new method for synthesizing chiral isotwistane and homoisotwistane skeletons as well as aminocyclitols in a highly stereoselective manner. These results were achieved through the use of a common intermediate, which was derived from the ytterbium-catalyzed asymmetric Diels-Alder reaction of Danishefsky diene.


Subject(s)
Alkanes/chemical synthesis , Bridged-Ring Compounds/chemical synthesis , Cyclitols/chemical synthesis , Cyclohexenes/chemistry , Alkanes/chemistry , Bridged-Ring Compounds/chemistry , Catalysis , Cyclitols/chemistry , Cycloaddition Reaction , Molecular Structure , Stereoisomerism , Ytterbium/chemistry
2.
Bioorg Med Chem Lett ; 25(15): 2972-5, 2015 Aug 01.
Article in English | MEDLINE | ID: mdl-26045033

ABSTRACT

Inhibition of amyloid-ß (Aß) aggregation could be a drug development target for treating Alzheimer disease. Insufficient activity to inhibit aggregation, however, remains a key issue. Here, we report a covalent modifier-type aggregation inhibitor of Aß, diazirine-equipped cyclo-KLVF(ß-Ph)F (2). Due to the affinity of the cyclo-KLVFF motif for Aß, 2 selectively reacted with Aß1-42 under UV-light irradiation to form an irreversible covalent bond. The Tyr-10 residue of Aß1-42 was identified as the covalent modification site with 2. The extent of cross-ß-sheet structure, characteristics of amyloid aggregation, and toxicity of Aß1-42 were strongly attenuated by this chemical modification.


Subject(s)
Amyloid beta-Peptides/chemistry , Amyloid beta-Peptides/metabolism , Amyloid beta-Peptides/pharmacology , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Peptide Fragments/pharmacology , Protein Aggregates/drug effects , Protein Aggregation, Pathological/drug therapy , Alzheimer Disease/drug therapy , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides/antagonists & inhibitors , Amyloid beta-Peptides/ultrastructure , Animals , Cell Line , Diazomethane/chemistry , Diazomethane/pharmacology , Humans , Peptide Fragments/antagonists & inhibitors , Peptide Fragments/ultrastructure , Peptides, Cyclic/chemistry , Peptides, Cyclic/pharmacology , Protein Aggregation, Pathological/metabolism , Protein Aggregation, Pathological/pathology , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...